dDepartment of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland eDepartment of Medicine I, Faculty of Medicine ...

When researcher Nicholas Tiller began to feed health questions into chatbots as a test, he expected some imperfections — but not this level of failure. Five AIs, 250 questions and a total score of ...

Women's health startup Midi Health recently passed a $1 billion valuation. Midi Health CEO Joanna Strober shared how AI has changed how she operates her business. Strober also spoke about her ...

Increasingly, teens and adults are turning to artificial intelligence chatbots for companionship and emotional support, recent studies and surveys show. And so, mental health care providers should ...

Using chatbots for emotional support can pose risks to teens' mental health. How should parents talk to their teens about using chatbots safely? And what's the best way to have those conversations ...

Ready your sides for a relentless laugh riot as we dive into some of the most iconic Monty Python one-liners ever written! From absurd insults to absurdist wit, these zingers perfectly showcase the ...

Seventy-five percent of U.S. health systems are now using at least one artificial intelligence application, up from 59% in 2025, a new survey from Eliciting Insights found. The go-to market research ...

Abstract: In today's society, mental health has become an important issue where many people experience stress and anxiety. The mental illness epidemic underscores the urgent need for support systems.

Karen Shimizu is the Executive Editor of Food & Wine. A seasoned editor and journalist who has worked on magazines, websites, cookbooks, and newspapers, Karen has been helping to shape the way ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. In today’s column, I examine a zesty proposition that the use of generative AI and large ...

The U.S. Food and Drug Administration (FDA) refused to consider Moderna’s application for a new flu vaccine using mRNA technology, the company announced Tuesday, a decision that could delay the ...